Juliet Marquez
Acute Care · South Miami, FLNPI 1154846624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,504, more than ten times the $52 reported in 2021. Among acute care clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$460
- Pfizer$360
- Boston Scientific$288
- Novo Nordisk$209
- E.r. Squibb & Sons, L.L.C.$194
- Bridgebio Pharma, Inc.$192
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,007100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 11 | $460 |
| Pfizer | 21 | $360 |
| Boston Scientific | 2 | $288 |
| Novo Nordisk | 10 | $209 |
| E.r. Squibb & Sons, L.L.C. | 9 | $194 |
| Bridgebio Pharma, Inc. | 7 | $192 |
| AstraZeneca | 11 | $190 |
| Kiniksa Pharmaceuticals International, PLC | 9 | $168 |
| Alnylam Pharmaceuticals Inc. | 6 | $147 |
| Merck | 2 | $120 |
| Lilly USA, LLC | 7 | $116 |
| Novartis | 5 | $93 |
| Bayer | 4 | $82 |
| Boehringer Ingelheim | 4 | $76 |
| Kestra Medical Technology Services, Inc. | 3 | $62 |
| Johnson & Johnson | 3 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| United Therapeutics Corporation | 1 | $32 |
| Medtronic | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$366
- WATCHMAN FLX$171
- Ozempic$117
- WATCHMAN Access System$117
- ZERBAXA$104
How this compares
$3,007 in reported general payments places this provider in the 90th percentile of 1,150 acute care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 56 | $67,395 |
| Repatha SureclickEvolocumab | 56 | $41,515 |
| EntrestoSacubitril/Valsartan | 38 | $33,358 |
| MounjaroTirzepatide | 13 | $10,365 |
| VascepaIcosapent Ethyl | 24 | $9,943 |
| OzempicSemaglutide | 13 | $9,821 |
| FarxigaDapagliflozin Propanediol | 13 | $8,593 |
| Isosorbide Dinitrate | 65 | $3,803 |
| Metoprolol Succinate | 112 | $1,545 |
| Nifedipine ErNifedipine | 60 | $1,510 |
| Losartan Potassium | 150 | $1,506 |
| Omega-3 Acid Ethyl Esters | 11 | $1,422 |
| Hydralazine Hcl | 99 | $1,356 |
| Atorvastatin Calcium | 122 | $1,081 |
| Nebivolol Hcl | 20 | $1,041 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $360 | $67,39556 claims |
| NovartisEntresto | $93 | $33,35838 claims |
| Lilly USA, LLCMounjaro | $116 | $10,36513 claims |
| Novo NordiskOzempic | $209 | $9,82113 claims |
| AstraZenecaFarxiga | $190 | $8,59313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,150 acute care providers in Florida.
Other acute care in South Miami
- Ailin Sierra HernandezSouth Miami$5K
- Adryanna RuizSouth Miami$5K
- Margarita PallaresSouth Miami$5K
- Melisa WilsonOrlando$214K
- Amanda PeacockJacksonville$81K
- Katrina RileyTampa$66K
- Diane GrayLake Mary$49K
- Heather RamousSafety Harbor$38K
- Melanie WeresJacksonville$37K
- Jayne JaramilloJacksonville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.